CARDIAC INVOLVEMENT IN CYSTIC FIBROSIS

View at publisher Summarise with VIRAT
Authors: Ulas Karadas
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cystic fibrosis (CF) is the most common fatal genetic disorder among Caucasians and results from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene located on chromosome 7. CFTR regulates the chloride (Cl-) channel, and its dysfunction leads to decreased Cl- secretion and increased sodium (Na+) reabsorption. This causes thick secretions in the respiratory tract, pancreas, and other glands. Consequently, patients experience recurrent respiratory infections, pancreatic insufficiency, and organ damage. Lung involvement occurs in about 90% of cases, and end-stage lung disease remains the leading cause of death.In recent years, CFTR expression has also been demonstrated in the cardiovascular system, including cardiac myocytes, the aorta, and pulmonary vessels. This suggests that CF may affect the cardiovascular system both directly and indirectly.In CF patients, cardiac involvement may arise from chronic hypoxemia and lung damage, leading to pulmonary hypertension and cor pulmonale. The right ventricle (RV) is typically affected due to prolonged hypoxia and increased pulmonary pressure. Even in the absence of pulmonary hypertension, subclinical RV dysfunction may be present. RV diastolic dysfunction and elevated pulmonary artery pressure are detected in 40-60% of patients. In children with CF, assessments using TAPSE (Tricuspid Annular Plane Systolic Excursion) and tissue Doppler imaging have shown significant reductions in RV systolic function. This is important for early detection of cardiac involvement. Hypoxia, inflammation, and endothelial dysfunction may eventually progress to right heart failure. Left ventricular (LV) involvement is rarer but can be detected even in infancy or alongside RV dysfunction. Persistent infections and hypoxemia may impair LV function via negative inotropic effects. Cardiac involvement may also manifest as fibrosis, necrosis, arrhythmias, and contractility disorders. The presence of CFTR in cardiac myocytes suggests that impaired chloride transport may affect contractile strength, calcium signaling, and fibrotic processes. Myocardial fibrosis may also result from vitamin deficiencies, chronic inflammation, and neuro-hormonal activation.In CF patients, the vascular system is affected due to CFTR dysfunction and systemic inflammation, leading to endothelial dysfunction and arterial stiffness.In conclusion, advances in CF treatment have significantly extended life expectancy; however, in the aging CF population, understanding and monitoring cardiovascular involvement are crucial for maintaining quality of life.Keywords: Cystic fibrosis; Heart ventricle; Blood vessels

Fields of Study & Subjects

Cystic Fibrosis Research Advances Pulmonary Hypertension Research and Treatments Cardiovascular Function and Risk Factors

Publication details

Journal / source
Turkiye Klinikleri eBooks
Pages
407–413
Publication date
1 January 2026
Language
EN
Document type
Book chapter